DMIIDrugs Made In America Acquisition II Corp.
10.07USD+0.10%Mkt Cap: 641.46M USDP/E: 77.46Last update: 2026-05-26
Drugs Made In America Acquisition II Corp. does not have significant operations. The company focuses on effecting a merger, share exchange, asset acquisition, share purchase, recapitalization, reorganization, or other si…
Industry Peers
Shell CompaniesIndicators:|
Key Statistics
Company
Market Cap641.46M USD
Enterprise Value640.29M USD
Revenue (TTM)—
Gross Profit—
Net Income (TTM)4.19M USD
Revenue/Share—
Last Price10.07 USD
Fiscal Year EndDec 2025
MR QuarterMar 2026
Employees—
CountryUS
SectorFinancial Services
IndustryShell Companies
ISIN—
Valuation
P/E (Trailing)77.46
P/E (Forward)—
PEG—
EV/EBITDA—
EV/Revenue—
P/S—
P/B-36.02
EPS (TTM)0.13
EPS (Forward)—
52W Range
9.860100% of range10.07
52W High10.07 USD
52W Low9.860 USD
Profitability
Gross Margin0.00%
Oper. Margin0.00%
EBITDA Margin0.00%
Profit Margin0.00%
ROE0.86%
ROA0.83%
Growth
Revenue Growth—
Earnings Growth—
Cash Flow & Leverage
Operating CF-1.02M USD
CapEx (TTM)—
FCF Margin—
FCF Yield—
Net Debt102.28K USD
Net Debt/EBITDA—
Balance Sheet
Debt/Equity—
Current Ratio0.53
Quick Ratio0.52
Book Value/Sh-0.2790 USD
Cash/Share0.0050 USD
Dividends
Fwd Div Rate—
Trail. Div Rate0.0000 USD
Div. Yield—
5Y Avg Yield—
Payout Ratio0.00%
Ex-Div Date—
Pay Date—
Analyst Consensus
Rating—
Target (Mean)—
Target Range—
# Analysts—
Ownership
Shares Out.63.70M
Float50.26M
Insiders15.21%
Institutions70.50%
Short Interest
Short Ratio0.3d
Short % Float0.07%
Short % Out.0.06%
Shares Short40.30K
Short (prev mo.)41.01K
Technical
SMA 5010.000 (+0.7%)
SMA 2009.966 (+1.0%)
Beta—
S&P 52W Chg28.31%
Avg Vol (30d)176.53K
Avg Vol (10d)61.09K
Technical Indicators
RSI (14)—
MACD—
MACD Signal—
MACD Hist.—
BB Upper—
BB Middle—
BB Lower—
BB Width—
ATR (14)—
Vol Ratio (20d)—